These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 9244221)

  • 21. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure.
    Hambrecht R; Schulze PC; Gielen S; Linke A; Möbius-Winkler S; Yu J; Kratzsch J Jü; Baldauf G; Busse MW; Schubert A; Adams V; Schuler G
    J Am Coll Cardiol; 2002 Apr; 39(7):1175-81. PubMed ID: 11923043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers.
    Tedeschi S; Pilotti E; Parenti E; Vicini V; Coghi P; Montanari A; Regolisti G; Fiaccadori E; Cabassi A
    Metabolism; 2012 Jan; 61(1):37-42. PubMed ID: 21696792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cardiac component of cardiac cachexia.
    Florea VG; Henein MY; Rauchhaus M; Koloczek V; Sharma R; Doehner W; Poole-Wilson PA; Coats AJ; Anker SD
    Am Heart J; 2002 Jul; 144(1):45-50. PubMed ID: 12094187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia.
    Brink M; Anwar A; Delafontaine P
    Int J Cardiol; 2002 Sep; 85(1):111-21, discussion 121-4. PubMed ID: 12163215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting.
    Anker SD; Clark AL; Kemp M; Salsbury C; Teixeira MM; Hellewell PG; Coats AJ
    J Am Coll Cardiol; 1997 Oct; 30(4):997-1001. PubMed ID: 9316530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wasting as independent risk factor for mortality in chronic heart failure.
    Anker SD; Ponikowski P; Varney S; Chua TP; Clark AL; Webb-Peploe KM; Harrington D; Kox WJ; Poole-Wilson PA; Coats AJ
    Lancet; 1997 Apr; 349(9058):1050-3. PubMed ID: 9107242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.
    Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Schwarz P; Faber J
    Endocrine; 2013 Jun; 43(3):626-34. PubMed ID: 23179776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia.
    Milani RV; Mehra MR; Endres S; Eigler A; Cooper ES; Lavie CJ; Ventura HO
    Chest; 1996 Oct; 110(4):992-5. PubMed ID: 8874257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.
    Anker SD; Volterrani M; Pflaum CD; Strasburger CJ; Osterziel KJ; Doehner W; Ranke MB; Poole-Wilson PA; Giustina A; Dietz R; Coats AJ
    J Am Coll Cardiol; 2001 Aug; 38(2):443-52. PubMed ID: 11499736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers for cardiac cachexia: reality or utopia.
    Martins T; Vitorino R; Amado F; Duarte JA; Ferreira R
    Clin Chim Acta; 2014 Sep; 436():323-8. PubMed ID: 24978823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches.
    Akashi YJ; Springer J; Anker SD
    Curr Heart Fail Rep; 2005 Dec; 2(4):198-203. PubMed ID: 16332313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology of peripheral muscle wasting in cardiac cachexia.
    Filippatos GS; Anker SD; Kremastinos DT
    Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):249-54. PubMed ID: 15809526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.
    Anker SD; Ponikowski PP; Clark AL; Leyva F; Rauchhaus M; Kemp M; Teixeira MM; Hellewell PG; Hooper J; Poole-Wilson PA; Coats AJ
    Eur Heart J; 1999 May; 20(9):683-93. PubMed ID: 10208789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure.
    Witte KK; Ford SJ; Preston T; Parker JD; Clark AL
    Int J Cardiol; 2008 Oct; 129(3):363-7. PubMed ID: 18022259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia.
    Martins T; Vitorino R; Moreira-Gonçalves D; Amado F; Duarte JA; Ferreira R
    Clin Biochem; 2014 Jan; 47(1-2):8-15. PubMed ID: 24184665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach.
    Pasini E; Aquilani R; Gheorghiade M; Dioguardi FS
    Ital Heart J; 2003 Apr; 4(4):232-5. PubMed ID: 12784775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
    Parissis JT; Venetsanou KF; Mentzikof DG; Ziras NG; Kefalas CG; Karas SM
    Scand Cardiovasc J; 1999; 33(6):344-50. PubMed ID: 10622546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased catabolic activity in adipose tissue of patients with chronic heart failure.
    Szabó T; Postrach E; Mähler A; Kung T; Turhan G; von Haehling S; Anker SD; Boschmann M; Doehner W
    Eur J Heart Fail; 2013 Oct; 15(10):1131-7. PubMed ID: 23696611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood ketone bodies in congestive heart failure.
    Lommi J; Kupari M; Koskinen P; Näveri H; Leinonen H; Pulkki K; Härkönen M
    J Am Coll Cardiol; 1996 Sep; 28(3):665-72. PubMed ID: 8772754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.